155 related articles for article (PubMed ID: 11887872)
1. In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits.
Passlick-Deetjen J; Pischetsrieder M; Witowski J; Bender TO; Jörres A; Lage C
Perit Dial Int; 2001; 21 Suppl 3():S96-101. PubMed ID: 11887872
[No Abstract] [Full Text] [Related]
2. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
Dawnay AB; Millar DJ
Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
Feriani M
Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
[No Abstract] [Full Text] [Related]
4. GDPs and AGEs: local and systemic effects in PD patients.
Ledebo I; Wieslander A; Deppisch R
Contrib Nephrol; 2003; (140):38-46. PubMed ID: 12800342
[No Abstract] [Full Text] [Related]
5. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
Park MS; Lee HB
Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
[No Abstract] [Full Text] [Related]
6. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
7. Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system.
Passlick-Deetjen J; Lage C
Perit Dial Int; 2000; 20 Suppl 2():S42-7. PubMed ID: 10911642
[No Abstract] [Full Text] [Related]
8. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
9. Strategy for preventing peritoneal dialysis failure.
Cancarini G
Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
[No Abstract] [Full Text] [Related]
10. Long-term results with low glucose degradation product content in peritoneal dialysis fluids.
Rippe B; Wieslander A; Musi B
Contrib Nephrol; 2003; (140):47-55. PubMed ID: 12800343
[No Abstract] [Full Text] [Related]
11. A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects.
Cappelli G; Amore A; Bandiani G; Cancarini G; Coppo R; Feriani M; Dell'Aquila R; Saffioti S; Spisni C; Stingone A; Orazi E; Ballocchi S; Renaux JL
Contrib Nephrol; 2001; (131):97-106. PubMed ID: 11125568
[No Abstract] [Full Text] [Related]
12. Biocompatibility of icodextrin.
Cooker LA; Holmes CJ; Hoff CM
Kidney Int Suppl; 2002 Oct; (81):S34-45. PubMed ID: 12230480
[No Abstract] [Full Text] [Related]
13. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
[TBL] [Abstract][Full Text] [Related]
14. Biologic significance of reduced levels of glucose degradation products.
Rippe B; Wieslander A
Perit Dial Int; 2001; 21 Suppl 3():S114-8. PubMed ID: 11887804
[No Abstract] [Full Text] [Related]
15. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
[TBL] [Abstract][Full Text] [Related]
16. Glucose degradation products: relationship with cell damage.
Witowski J; Jörres A
Perit Dial Int; 2000; 20 Suppl 2():S31-6. PubMed ID: 10911640
[No Abstract] [Full Text] [Related]
17. Impact of glucose in peritoneal dialysis: saint or sinner?
Sitter T; Sauter M
Perit Dial Int; 2005; 25(5):415-25. PubMed ID: 16178471
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
[TBL] [Abstract][Full Text] [Related]
19. Strategies to reduce glucose exposure in peritoneal dialysis patients.
Holmes CJ; Shockley TR
Perit Dial Int; 2000; 20 Suppl 2():S37-41. PubMed ID: 10911641
[TBL] [Abstract][Full Text] [Related]
20. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
